There’s a clear gap: output is rising, but engagement isn’t. This often happens because many strategies focus on HCPs’ ...

Medical Affairs is operating at a pivotal moment. Expectations have expanded rapidly – deeper scientific exchange, sharper ...

Johnson & Johnson (J&J) has announced US FDA approval for Tecvayli (teclistamab-cqyv) plus Darzalex Faspro (daratumumab and hyaluronidase-fihj) to treat adults with relapsed or refractory multiple ...

Johnson & Johnson’s (J&J) nipocalimab, a potential immunoselective investigational treatment for adults with systemic lupus ...

Building on proven methodology, STEM AI was developed to provide an even deeper level of insight for organisations looking to use generative AI to further accelerate team performance. Drawing on ...

The Gilead Foundation has announced a $12m investment in 33 community-based organisations across 14 US states and Washington DC through its Community Health Worker (CHW) Comprehensive HIV Prevention ...

Novo Nordisk has announced it will invest 432m euros in its facility in Ireland. The tabletting facility, in Monksland, Athlone, will provide significant additional manufacturing capacity for current ...

The 2025 edition of PMLiVE’s T40 list of creative agencies working on advertising, branding, creative and design projects in the UK healthcare sector has been published. The sixth edition of the list ...

UK biotech N4 Pharma, a company developing a gene delivery system to enable advanced therapies for cancer and other diseases, ...

Despite the GenAI fervour, there is an acute need to prepare organisations to understand which specific tools they need and ...

CNX Therapeutics, a specialty pharmaceutical company, has appointed Erin Federman as a non-executive director, effective from ...

Stop pushing content at a burnt-out audience and start creating "Digital Magnetism." Join Impetus Digital to unlock the 2026 ...